Bolenol

From Wikipedia, the free encyclopedia
Bolenol
Clinical data
Other namesEthylnorandrostenol; 17α-Ethyl-19-norandrost-5-en-17β-ol
Routes of
administration
By mouth
Identifiers
  • (8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,4,7,8,9,10,11,12,14,15, 16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
ECHA InfoCard100.037.226 Edit this at Wikidata
Chemical and physical data
FormulaC20H32O
Molar mass288.475 g·mol−1
3D model (JSmol)
  • CC[C@@]1(CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@H]3CCCC4)C)O
  • InChI=1S/C20H32O/c1-3-20(21)13-11-18-17-9-8-14-6-4-5-7-15(14)16(17)10-12-19(18,20)2/h8,15-18,21H,3-7,9-13H2,1-2H3/t15-,16+,17+,18-,19-,20-/m0/s1 ☒N
  • Key:VGXLQFPZGUQVQW-XGXHKTLJSA-N ☒N
 ☒NcheckY (what is this?)  (verify)

Bolenol (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name), also known as 17α-ethyl-19-norandrost-5-en-17β-ol (ethylnorandrostenol), is a synthetic, orally active anabolic-androgenic steroid (AAS) and a 17α-alkylated derivative of 19-nortestosterone (nandrolone) that was never marketed.[1] It was described in the literature in 1969.[1]

See also[edit]

References[edit]

  1. ^ a b Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 168–. ISBN 978-1-4757-2085-3.